Palisade Bio, Inc.
PALI
$2.14
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.27% | 14.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.49% | 7.68% | |||
| Operating Income | -8.84% | -7.68% | |||
| Income Before Tax | -10.15% | -7.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.15% | -7.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.15% | -7.88% | |||
| EBIT | -8.84% | -7.68% | |||
| EBITDA | -8.84% | -7.68% | |||
| EPS Basic | -9.17% | -5.77% | |||
| Normalized Basic EPS | -9.44% | -5.54% | |||
| EPS Diluted | -9.17% | -5.77% | |||
| Normalized Diluted EPS | -9.44% | -5.54% | |||
| Average Basic Shares Outstanding | 0.82% | 1.99% | |||
| Average Diluted Shares Outstanding | 0.82% | 1.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||